semaglutide + cagrilintide Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial Cagrilintide–semaglutide (CagriSema) versus semaglutide or

Signals from the gut influence appetite, satiety, and energy balance through: The vagus nerve Hormonal signaling Microbial metabolites Key metabolic hormones produced or influenced by the gut include: GLP-1 (glucagon-like peptide-1) enhances insulin secretion and promotes satiety Peptide YY (PYY) signals fullness Ghrelin stimulates hunger When gut health is disrupted, these signals can become dysregulated, potentially contributing to overeating or impaired metabolic control

BHRC BLOG How to prepare for Semaglutide therapy: The Complete Guide Starting semaglutide therapy can feel overwhelming, especially when you want to maximize your results from day one

Monitoring Protocol for Patients Using Both Agents If a patient and their prescriber decide to proceed with concurrent use after informed consent, the following monitoring protocol applies

Start by checking the supplier sheet before opening the tube